Skip to main content

Advertisement

Log in

Negative chronotropic and inotropic effects of class I antiarrhythmic drugs assessed in isolated canine blood-perfused sinoatrial node and papillary muscle preparations

  • Originals
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Summary

The present study was designed to assess the negative chronotropic and inotropic effects of 10 class I antiarrhythmic drugs, using isolated canine blood-perfused sinoatrial node and papillary muscle preparations. Each drug showed negative chronotropic and inotropic effects in a dose-related manner. The potency of the suppressive effect on the sinoatrial automaticity was in the order of aprindine, quinidine, flecainide, lidocaine, mexiletine, cibenzoline, disopyramide, procainamide, tocainide, and phenytoin, while the effect on the ventricular contraction was in the order of aprindine, flecainide, cibenzoline, lidocaine, mexiletine, disopyramide, tocainide, phenytoin, quinidine, and procainamide. The differences in the suppressive effects could not necessarily be explained by their subclassification, based either on action potential duration or kinetic properties of dissociation or association with sodium channels. On the other hand, we found a good correlation between the negative inotropic effects of class I drugs in this study and the canine antiarrhythmic plasma concentrations for the digitalis- and coronary ligation-induced ventricular arrhythmia models in our previous studies. However, the negative chronotropic effects of the drugs showed a poor correlation with the antiarrhythmic plasma drug concentrations. The data shown in this paper may provide a convenient guideline for predicting acute cardiosuppressive effects of antiarrhythmic drugs, especially in patients with reduced cardiac function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene HL, Huther ML, Richardson DW (The CAST Investigators) (1991) Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 324:781–788

    Article  PubMed  CAS  Google Scholar 

  2. Waldo AL, Camm AJ, deRuyter H, Friedman PL, MacNeil DJ, Pauls JF, Pitt B, Pratt CM, Schwartz PJ, Veltri EP (1996) Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol. Lancet 348:7–12

    Article  PubMed  CAS  Google Scholar 

  3. Kodama I, Ogawa S, Inoue H, Kasanuki H, Kato T, Mitamura H, Hiraoka M, Sugimoto T. The Guideline Committee for Clinical Use of Antiarrhythmic Drugs in Japan (1999) Profiles of aprindine, cibenzoline, pilsicainide and pirmenol in the framework of the Sicilian Gambit. Jpn Circ J 63:1–12

    Article  PubMed  CAS  Google Scholar 

  4. Members of the Sicilian Gambit (1994) Antiarrhythmic therapy. A pathophysiological approach. Futura, New York

    Google Scholar 

  5. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. The Sicilian Gambit (1991) A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Circulation 84:1831–1851

    Google Scholar 

  6. Sugiyama A, Motomura S, Tamura K, Hashimoto K (1990) Comparison of cardiovascular effects of pirmenol with those of disopyramide in isolated canine heart preparations cross-circulated with a donor dog. Jpn J Pharmacol 53:97–110

    PubMed  CAS  Google Scholar 

  7. Sugiyama A, Motomura S, Hashimoto K (1994) Utilization of an isolated, blood-perfused canine papillary muscle preparation as a model to assess efficacy and adversity of class I antiarrhythmic drugs. Jpn J Pharmacol 66:303–316

    PubMed  CAS  Google Scholar 

  8. Hashimoto K, Sugiyama A, Haruno A, Matsuzaki T, Hirasawa A (1991) Effects of new antiarrhythmic drug TYB-3823 on canine ventricular arrhythmia models. J Cardiovasc Pharmacol 17:336–342

    PubMed  CAS  Google Scholar 

  9. Hashimoto K, Haruno A, Matsuzaki T, Sugiyama A, Akiyama K (1991) Effects of antiarrhythmic drugs on canine ventricular arrhythmia models: which electrophysiological characteristics of drugs are related to their effectiveness? Cardiovasc Drugs Ther 5:805–818

    Article  PubMed  Google Scholar 

  10. Endoh M, Hashimoto K (1970) Pharmacological evidence of autonomic nerve activities in canine papillary muscle. Am J Physiol 218:1459–1463

    PubMed  CAS  Google Scholar 

  11. Kubota K, Hashimoto K (1973) Selective stimulation of the parasympathetic preganglionic nerve fibers in the excised and blood-perfused SA node preparation of the dog. Naunyn Schmiedebergs Arch Pharmacol 278:135–150

    Article  PubMed  CAS  Google Scholar 

  12. Sugiyama A, Motomura S, Hashimoto K (1991) Comparison of cardiovascular effects of a novel class Ic antiarrhythmic agent, NIK-244 with those of flecainide in isolated canine heart preparations cross-circulated with a donor dog. Jpn J Pharmacol 56:1–12

    PubMed  CAS  Google Scholar 

  13. Sugiyama A, Xue YX, Hagihara A, Saitoh M, Hashimoto K (1996) Characterization of magnesium sulfate as an antiarrhythmic agent. J Cardiovasc Pharmacol Ther 1:243–254

    PubMed  CAS  Google Scholar 

  14. Vaughan Williams EM (1984) A classification of antiarrhythmic actions reassessed after a decade of new drugs. J Clin Pharmacol 24:129–147

    PubMed  CAS  Google Scholar 

  15. Josephson ME (1993) Sinus node function. In: Josephson ME (ed) Clinical cardiac electrophysiology: techniques and interpretations, 2nd ed. Lea & Febiger, Philadelphia, pp. 71–95

    Google Scholar 

  16. Satoh H, Nakajima T, Hashimoto K, Imai S (1981) Effects of lidocaine and procaine on the action potential of canine sinus nodal cells. Jpn Heart J 22:929–937

    PubMed  CAS  Google Scholar 

  17. Satoh H, Hashimoto K (1984) Effects of lidocaine on membrane currents in rabbit sino-atrial node cells. Arch Int Pharmacodyn Ther 270:241–254

    PubMed  CAS  Google Scholar 

  18. Satoh H, Hashimoto K (1986) Electrophysiological effects of procaine in rabbit sino-atrial node cells. Jpn J Pharmacol 40:83–93

    PubMed  CAS  Google Scholar 

  19. Jalife J, Delmer M, Davidenko JM, Anumonwo JMB (1999) Basic cardiac electrophysiology for the clinician. Futura, New York

    Google Scholar 

  20. Honerjäger P, Loibl E, Steidl I, Schönsteiner G, Ulm K (1986) Negative inotropic effects of tetrodotoxin and seven class I antiarrhythmic drugs in relation to sodium channel blockade. Naunyn Schmiedebergs Arch Pharmacol 332:184–195

    Article  PubMed  Google Scholar 

  21. Ito K, Nakafuchi K, Taga A, Yorikane R, Koike H (1996) Possible involvement of altered Na+-Ca2+ exchange in negative inotropic effects of class I antiarrhythmic drugs on rabbit and rat ventricles. J Cardiovasc Pharmacol 27:355–361

    Article  PubMed  CAS  Google Scholar 

  22. Kihara Y, Inoko M, Hatakeyama N, Momose Y, Sasayama S (1996) Mechanisms of negative inotropic effects of class Ic antiarrhythmic agents: comparative study of the effects of flecainide and pilsicainide on intracellular calcium handling in dog ventricular myocardium. J Cardiovasc Pharmacol 27:42–51

    Article  PubMed  CAS  Google Scholar 

  23. Nawada T, Tanaka Y, Hirai S, Hisatomi I, Hasegawa J, Kotake H, Mashiba H (1994) Evaluation of negative inotropic and antiarrhythmic effects of class I antiarrhythmic drugs. Int J Clin Pharmacol Ther 32:347–355

    PubMed  CAS  Google Scholar 

  24. Harrison DC, Sprause JH, Morrow AG (1963) The antiarrhythmic properties of lidocaine and procaine amide. Circulation 28:486–491

    PubMed  CAS  Google Scholar 

  25. Mullins LJ (1979) The generation of electric currents in cardiac fibers by Na/Ca exchange. Am J Physiol 236:C103–110

    PubMed  CAS  Google Scholar 

  26. Himori N, Ono H, Taira N (1976) Simultaneous assessment of effects of coronary vasodilators on the coronary blood flow and the myocardial contractility by using the blood-perfused canine papillary muscle. Jpn J Pharmacol 26:427–435

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sugiyama, A., Takehana, S., Kimura, R. et al. Negative chronotropic and inotropic effects of class I antiarrhythmic drugs assessed in isolated canine blood-perfused sinoatrial node and papillary muscle preparations. Heart Vessels 14, 96–103 (1999). https://doi.org/10.1007/BF02481749

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02481749

Key words

Navigation